Discounted Cash Flow Rating
Neutral
Return on Equity Rating
Sell
Debt to Equity Rating
Strong Buy
Price to Earnings Rating
Buy
Analyst Rating
Neutral
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Standard Deviation
Strong Sell
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Neutral
Wall Street Data Solutions Rating
Neutral
B
P3 Health Partners Inc. Warrant (PIIIW)
Services-health Services
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver highly coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering a better experience for all.
2045 W GRAND AVE STE B, PMB # 82152
CHICAGO, IL
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
12/06/2021
Market Cap
211,054,242
Shares Outstanding
114,250,000
Weighted SO
N/A
Total Employees
N/A
Upcoming Earnings
N/A
Similar Tickers
Beta
1.1930
Last Div
0.0000
Range
0.035-0.035
Chg
-0.0003
Avg Vol
N/A
Mkt Cap
211054242
Exch
NASDAQ
Country
US
Phone
702-910-3950
DCF Diff
N/A
DCF
0.0000
Div Yield
0.0000
P/S
0.1537
EV Multiple
-3.2787
P/FV
0.4934
Div Yield %
0.0000
P/E
-1.1848
PEG
-0.0392
Payout
0.0000
Current Ratio
0.6873
Quick Ratio
0.6873
Cash Ratio
0.2220
DSO
40.4387
DIO
0.0000
Op Cycle
40.4387
DPO
65.2249
CCC
-24.7861
Gross Margin
-0.0555
Op Margin
-0.1235
Pretax Margin
-0.1280
Net Margin
-0.0495
Eff Tax Rate
-0.0291
ROA
-0.0778
ROE
-0.4319
ROCE
-0.3205
NI/EBT
0.3869
EBT/EBIT
1.0364
EBIT/Rev
-0.1235
Debt Ratio
0.1500
D/E
0.8029
LT Debt/Cap
0.4438
Total Debt/Cap
0.4453
Int Coverage
-25.2250
CF/Debt
-0.4011
Equity Multi
5.3510
Rec Turnover
9.0260
Pay Turnover
5.5960
Inv Turnover
0.0000
FA Turnover
186.1294
Asset Turnover
1.5714
OCF/Share
-0.3934
FCF/Share
-0.3947
Cash/Share
0.5725
OCF/Sales
-0.0383
FCF/OCF
1.0033
CF Coverage
-0.4011
ST Coverage
-64.6643
CapEx Coverage
-307.0629
Div&CapEx Cov
-307.0629
P/BV
0.4934
P/B
0.4934
P/S
0.1537
P/E
-1.1848
P/FCF
-3.9985
P/OCF
-1.5319
P/CF
-1.5319
PEG
-0.0392
P/S
0.1537
EV Multiple
-3.2787
P/FV
0.4934
DPS
0.0000
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
3 - 6 Months
770.99K Shares Bought (50.00 %)
770.99K Shares Sold (50.00%)
6 - 9 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
9 - 12 Months
5.23M Shares Bought (100.00 %)
0.00 Shares Sold (0.00 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2020 | 2022 | 2023 | 2023 | 2024 | 1970 | 1970 | |
---|---|---|---|---|---|---|---|
Revenue | 116.86M | ▲ 490.60B | ▼ 258.20M | ▲ 346.86M | ▲ 388.49M | ▼ | |
Cost Of Revenue | 0.00 | 0.00 | ▲ 291.18M | ▲ 389.31M | ▲ 403.60M | ▼ | |
Gross Profit | 116.86M | ▲ 490.60B | ▼ -32.98M | ▼ -42.45M | ▲ -15.11M | ▼ | |
Gross Profit Ratio | 1.00 | 1.00 | ▼ -0.13 | ▲ -0.12 | ▲ -0.04 | ▼ | |
Research And Development Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
General And Administrative Expenses | 11.77M | ▲ 53.34B | ▼ 39.70M | ▼ 24.43M | ▲ 27.40M | ▼ | |
Selling And Marketing Expenses | 149.13K | ▲ 1.50B | ▼ 1.70M | ▼ 721.00K | ▼ 322.00K | ▼ | |
Selling General And Administrative Expenses | 11.92M | ▲ 54.84B | ▼ 41.40M | ▼ 25.15M | ▲ 27.72M | ▼ | |
Other Expenses | 0.00 | ▲ 464.29B | ▼ 289.90M | ▼ 3.34M | ▼ -1.00M | ▼ | |
Operating Expenses | 121.53M | ▲ 519.13B | ▼ 331.30M | ▼ 21.81M | ▲ 28.72M | ▼ | |
Cost And Expenses | 121.53M | ▲ 519.13B | ▼ 331.30M | ▲ 411.12M | ▲ 432.32M | ▼ | |
Interest Income | 0.00 | 0.00 | ▲ 3.16M | ▼ 0.00 | 0.00 | ||
Interest Expense | 0.00 | ▼ -2.53B | ▲ 3.20M | ▲ 4.05M | ▲ 4.26M | ▼ | |
Depreciation And Amortization | 188.84K | ▲ 13.29M | ▲ 22.00M | ▼ 21.63M | ▼ 21.54M | ▼ | |
Ebitda | -4.47M | ▼ -33.85B | ▲ -48.30M | ▲ -42.63M | ▲ -22.29M | ▼ | |
Ebitda Ratio | -0.04 | ▼ -0.07 | ▼ -0.19 | ▲ -0.12 | ▲ -0.06 | ▼ | |
Operating Income | -4.66M | ▲ 60.55M | ▼ -536.50M | ▲ -64.26M | ▲ -43.83M | ▼ | |
Operating Income Ratio | -0.04 | ▲ 0.00 | ▼ -2.08 | ▲ -0.19 | ▲ -0.11 | ▼ | |
Total Other Income Expenses Net | 0.00 | ▼ -31.39B | ▲ -454.20M | ▲ -3.08M | ▼ -3.70M | ▼ | |
Income Before Tax | -6.96M | ▼ -31.33B | ▲ -530.50M | ▲ -67.34M | ▲ -47.53M | ▼ | |
Income Before Tax Ratio | -0.06 | ▼ -0.06 | ▼ -2.05 | ▲ -0.19 | ▲ -0.12 | ▼ | |
Income Tax Expense | 0.00 | ▼ -13.63M | ▲ 1.90M | ▼ 1.77M | ▲ 2.07M | ▼ | |
Net Income | -4.19M | ▲ 76.09M | ▼ -94.03M | ▲ -25.46M | ▲ -18.70M | ▼ | |
Net Income Ratio | -0.04 | ▲ 0.41 | ▼ -0.36 | ▲ -0.07 | ▲ -0.05 | ▼ | |
Eps | -0.06 | ▲ 1.83 | ▼ -2.26 | ▲ -0.27 | ▲ -0.16 | ▼ | |
Eps Diluted | -0.06 | ▲ 1.83 | ▼ -2.26 | ▲ -0.09 | ▼ -0.16 | ▼ | |
Weighted Average Shs Out | 66.29M | ▼ 41.58M | 41.58M | ▲ 94.89M | ▲ 118.89M | ▼ | |
Weighted Average Shs Out Dil | 66.29M | ▼ 41.58M | ▼ 41.58M | ▲ 294.59M | ▼ 118.89M | ▼ |